None listed
Conditions
Interventions
Dietary Supplement : After taking the trial food and placebo for 12 weeks, we examine the efficacy and the safety of OFE.
Sponsors
Koreaeundan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: With subjective memory complaints With Literacy Who have scores in memroy domains of CERAD-K below -1.0 SD Who agree informed consent
Exclusion criteria
Exclusion criteria: Inpatient or within 3 months after discharge with malignancy, severe cerebrovascular diseasd, severe cardiac disease Schizophrenia, major depressive disorder Dementia, Parkinson disease, cerebral infarction The patient who taking the cerebral enhancer test before 4 weeks The patient who taking more than 400IU of vitamin E Alcohol abuse or dependence Thyroid disease Renal or hepatic dysfunction Uncontrolled high blood glucose and high blood preasure Pregnancy or breast feeding The patient who involved with 3 months with other human clinical trial The patient who is not suitable for this clinical trial by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog);memory score of ADAS-cog;Alzeheimer's Disease Assement Scale-Korean Version (ADAS-K);Visual Continuous Performance Test (Visual CPT);Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL);Short form of Geriatric Depression Sclae (SGDS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect;Laboratory tests;Vital signs;Weight | — |
Countries
Korea, Republic of
Contacts
Public ContactSeung-Ho Ryu
Konkuk University Medical Center
Outcome results
None listed